Articles with public access mandates - Dr. Abhisheak SharmaLearn more
Not available anywhere: 14
Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agents
M Sharma, K Chauhan, R Shivahare, P Vishwakarma, MK Suthar, ...
Journal of Medicinal Chemistry 56 (11), 4374-4392, 2013
Mandates: Council of Scientific and Industrial Research, India
A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin
M Shukla, S Jaiswal, A Sharma, PK Srivastava, A Arya, AK Dwivedi, J Lal
Drug development and industrial pharmacy 43 (5), 847-861, 2017
Mandates: Council of Scientific and Industrial Research, India
Role of enterohepatic recirculation in drug disposition: cooperation and complications
MY Malik, S Jaiswal, A Sharma, M Shukla, J Lal
Drug metabolism reviews 48 (2), 281-327, 2016
Mandates: Council of Scientific and Industrial Research, India
Lyophilized kratom tea as a therapeutic option for opioid dependence
LL Wilson, HM Harris, SO Eans, AC Brice-Tutt, TJ Cirino, HM Stacy, ...
Drug and Alcohol Dependence 216, 108310, 2020
Mandates: US National Institutes of Health
Comparative pharmacokinetics of mitragynine after oral administration of Mitragyna speciosa (Kratom) leaf extracts in rats
BA Avery, SP Boddu, A Sharma, EB Furr, F Leon, SJ Cutler, CR McCurdy
Planta medica 85 (04), 340-346, 2019
Mandates: US National Institutes of Health
Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one …
S Intagliata, A Sharma, TI King, C Mesangeau, M Seminerio, FT Chin, ...
The AAPS Journal 22, 1-11, 2020
Mandates: US Department of Defense, US National Institutes of Health
In vitro and in vivo pharmacology of kratom
T Hiranita, S Obeng, A Sharma, JL Wilkerson, CR McCurdy, LR McMahon
Advances in pharmacology 93, 35-76, 2022
Mandates: US National Institutes of Health
Preclinical pharmacokinetics and ADME characterization of a novel anticancer chalcone, cardamonin
S Jaiswal, M Shukla, A Sharma, N Rangaraj, K Vaghasiya, MY Malik, ...
Drug testing and analysis 9 (8), 1124-1136, 2017
Mandates: Council of Scientific and Industrial Research, India
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
CR McCurdy, A Sharma, KE Smith, CA Veltri, ST Weiss, CM White, ...
Expert Review of Clinical Pharmacology 17 (2), 131-142, 2024
Mandates: US National Institutes of Health
A mechanistic investigation of the bioavailability enhancing potential of lysergol, a novel bioenhancer, using curcumin
M Shukla, MY Malik, S Jaiswal, A Sharma, DK Tanpula, R Goyani, J Lal
RSC advances 6 (64), 58933-58942, 2016
Mandates: Council of Scientific and Industrial Research, India
Quantification of highly selective sigma‐1 receptor antagonist CM304 using liquid chromatography tandem mass spectrometry and its application to a pre‐clinical pharmacokinetic …
BA Avery, PK Vuppala, S Jamalapuram, A Sharma, C Mesangeau, ...
Drug testing and analysis 9 (8), 1236-1242, 2017
Mandates: US National Institutes of Health
Characterization of different forms of kava (Piper methysticum) products by UPLC-MS/MS
J Mamallapalli, SRR Kanumuri, P Corral, E Johnston, C Zhuang, ...
Planta Medica 88 (14), 1348-1359, 2022
Mandates: US National Institutes of Health
LC-coupled ESI MS for quantification of miltefosine in human and hamster plasma
S Jaiswal, A Sharma, M Shukla, J Lal
Bioanalysis 8 (6), 533-545, 2016
Mandates: Council of Scientific and Industrial Research, India
Model based population PK-PD analysis of furosemide for BP lowering effect: A comparative study in primary and secondary hypertension
M Shukla, MMA Ibrahim, M Jain, S Jaiswal, A Sharma, K Hanif, J Lal
European Journal of Pharmaceutical Sciences 109, 253-261, 2017
Mandates: Council of Scientific and Industrial Research, India
Available somewhere: 58
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
S Khan, X Zhang, D Lv, Q Zhang, Y He, P Zhang, X Liu, D Thummuri, ...
Nature medicine 25 (12), 1938-1947, 2019
Mandates: US Department of Defense, US National Institutes of Health, Cancer …
Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom …
S Obeng, SH Kamble, ME Reeves, LF Restrepo, A Patel, M Behnke, ...
Journal of medicinal chemistry 63 (1), 433-439, 2019
Mandates: US National Institutes of Health
Suspected adulteration of commercial kratom products with 7-hydroxymitragynine
AG Lydecker, A Sharma, CR McCurdy, BA Avery, KM Babu, EW Boyer
Journal of Medical Toxicology 12, 341-349, 2016
Mandates: US National Institutes of Health
Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra‐performance liquid chromatography …
A Sharma, SH Kamble, F León, NJY Chear, TI King, EC Berthold, ...
Drug testing and analysis 11 (8), 1162-1171, 2019
Mandates: US National Institutes of Health
Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin
VK Pawar, Y Singh, K Sharma, A Shrivastav, A Sharma, A Singh, ...
International journal of biological macromolecules 122, 1100-1114, 2019
Mandates: Council of Scientific and Industrial Research, India, Department of Science …
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis
S Singh, KK Roy, SR Khan, VK Kashyap, A Sharma, S Jaiswal, ...
Bioorganic & Medicinal Chemistry 23 (4), 742-752, 2015
Mandates: Council of Scientific and Industrial Research, India
Publication and funding information is determined automatically by a computer program